Kelly McLean, MD
Surgical Oncology · Cincinnati, OHNPI 1942237318
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,249 of the $1,811 with a category attached, or 68.9%. Medtronic accounts for 81.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $1,580 and has fallen 96.7% since, to $52 in 2025.
Across 21 payments — averaging $86.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Tactile Systems Technology Inc$109
- E.r. Squibb & Sons, L.L.C.$100
- Molli Surgical (US) Inc$70
- Spectrum Pharmaceuticals Inc.$30
- Hologic Sales And Service, LLC$18
- plus $16 from 1 others
What the payments were for
- Travel & lodging$1,24969%
- Food & beverage$56331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $1,468 |
| Tactile Systems Technology Inc | 6 | $109 |
| E.r. Squibb & Sons, L.L.C. | 1 | $100 |
| Molli Surgical (US) Inc | 2 | $70 |
| Spectrum Pharmaceuticals Inc. | 1 | $30 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Solventum Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PlasmaBlade$1,293
- OPDIVO$100
How this compares
$1,811 in reported general payments places this provider in the 60th percentile of 69 surgical oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 96 | $590 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 64 | $257 |
| Anastrozole | 15 | $181 |
| Tamoxifen Citrate | 11 | $163 |
| Tramadol Hcl | 27 | $69 |
| Lorazepam | 21 | $11 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Cincinnati
- Syed AhmadCincinnati$59K
- Alicia HeelanCincinnati$9K
- Sameer PatelCincinnati$4K
- Gregory WilsonCincinnati$4K
- Erik Dunki JacobsCincinnati$3K
- Shyam AllamaneniCincinnati$3K
- Elizabeth ShaughnessyCincinnati$2K
- Be SaitoCincinnati$1K
- Jeffrey SussmanCincinnati$628
- Jennifer MandersCincinnati$248
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.